← All organizations
First clinical trial
Feb 28, 2014Last known activity
Sep 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (18 distinct, 17 trials)
Other trials (18 own, 0 via acquisition)
Recent trials (48)
- NCT06163937Reponsible party - principal investigatorN/ASep 1, 2023
- NCT06163937Lead sponsorN/ASep 1, 2023
- NCT06163937Overall official - principal investigatorN/ASep 1, 2023
- NCT05702359Reponsible party - principal investigatorN/ANov 2, 2022
- NCT05702359Overall official - principal investigatorN/ANov 2, 2022
- NCT05702359Lead sponsorN/ANov 2, 2022
- NCT05702307Overall official - principal investigatorN/AOct 15, 2022
- NCT05702307Reponsible party - principal investigatorN/AOct 15, 2022
- NCT05702307Lead sponsorN/AOct 15, 2022
- NCT05702372Reponsible party - principal investigatorN/ASep 19, 2022
- NCT05702372Lead sponsorN/ASep 19, 2022
- NCT05702372Overall official - principal investigatorN/ASep 19, 2022
- NCT05484336Reponsible party - principal investigatorN/AJun 7, 2022
- NCT05484336Lead sponsorN/AJun 7, 2022
- NCT05484336Overall official - principal investigatorN/AJun 7, 2022
Details
- Last known activity
- Sep 1, 2023